« Previous
Next »
BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 4
, Pages
187-199
, October 2010
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study
To access this article, please choose from the options below
Supported by a grant from Neuronetics Inc. (Grant 44-01103-000).
Clinical trial posted on www.clinicaltrials.gov. Listing No. NCT 00104611.
L.B.M. is currently employed at Eli Lilly and Company, Indianapolis, IN.
PII: S1935-861X(10)00110-5
doi: 10.1016/j.brs.2010.07.003
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 4
, Pages
187-199
, October 2010
